Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas

被引:31
作者
Arnold, JM
Mok, SC
Purdie, D
Chenevix-Trench, G
机构
[1] Queensland Inst Med Res, Herston, Qld 4029, Australia
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol,Lab Gynecol Onc, Boston, MA 02115 USA
[3] Univ Queensland, Dept Pathol, Brisbane, Qld 4067, Australia
基金
英国医学研究理事会;
关键词
ovarian cancer; tumour suppressor gene; Id3; cDNA array; loss of heterozygosity;
D O I
10.1054/bjoc.2000.1620
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The molecular events that drive the initiation and progression of ovarian adenocarcinoma are not well defined. We have investigated changes in gene expression in ovarian cancer cell lines compared to an immortalized human ovarian surface epithelial cell line (HOSE) using a cDNA array. We identified 17 genes that were under-expressed and 10 genes that were over-expressed in the cell lines compared to the HOSE cells. One of the genes under-expressed in the ovarian cancer cell lines, Id3, a transcriptional inactivator, was selected for further investigation. Id3 mRNA was expressed at reduced levels in 6 out of 9 ovarian cancer cell lines compared to the HOSE cells while at the protein level, all 7 ovarian cancer cell lines examined expressed the Id3 protein at greatly reduced levels. Expression of Id3 mRNA was also examined in primary ovarian tumours and was found in only 12/38 (32%) cases. A search was conducted far mutations of Id3 in primary ovarian cancers using single stranded conformation polymorphism (SSCP) analysis. Only one nucleotide substitution, present also in the corresponding constitutional DNA, was found in 94 ovarian tumours. Furthermore no association was found between LOH at 1p36 and lack of expression of Id3. These data suggest that Id3 is not the target of LOH at 1p36. (C) 2001 Cancer Research Campaign.
引用
收藏
页码:352 / 359
页数:8
相关论文
共 61 条
[1]   DIFFERENCES AND SIMILARITIES IN DNA-BINDING PREFERENCES OF MYOD AND E2A PROTEIN COMPLEXES REVEALED BY BINDING-SITE SELECTION [J].
BLACKWELL, TK ;
WEINTRAUB, H .
SCIENCE, 1990, 250 (4984) :1104-1110
[2]  
Bruening W, 1999, CANCER RES, V59, P4973
[3]  
BUICK RN, 1985, CANCER RES, V45, P3668
[4]  
CHENEVIXTRENCH G, 1992, ONCOGENE, V7, P1059
[5]   STRUCTURAL ORGANIZATION AND CHROMOSOMAL MAPPING OF THE HUMAN ID-3 GENE [J].
DEED, RW ;
HIROSE, T ;
MITCHELL, ELD ;
SANTIBANEZKOREF, MF ;
NORTON, JD .
GENE, 1994, 151 (1-2) :309-314
[6]  
Fogh J., 1975, HUMAN TUMOR CELLS IN, P155
[7]  
Foster KA, 1996, CANCER RES, V56, P3622
[8]  
HAMILTON TC, 1983, CANCER RES, V43, P5379
[9]   Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target [J].
Imyanitov, EN ;
Birrell, GW ;
Filippovich, I ;
Sorokina, N ;
Arnold, J ;
Mould, MA ;
Wright, K ;
Walsh, M ;
Mok, SC ;
Lavin, MF ;
Chenevix-Trench, G ;
Khanna, KK .
ONCOGENE, 1999, 18 (32) :4640-4642
[10]  
Israel MA, 1999, CANCER RES, V59, p1726S